NCT05824858View on ClinicalTrials.gov

A Study of the Effect of Food on LY3537982 in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

April 12, 2023

Primary Completion Date

June 17, 2023

Study Completion Date

June 17, 2023

Conditions

Healthy

Interventions

DRUG

LY3537982

Administered orally.

Trial Locations (1)

84124

ICON, Salt Lake City

Sponsors

Collaborators (1)

Loxo Oncology, Inc.

All Listed Sponsors

collaborator

Loxo Oncology, Inc.

INDUSTRY

lead

Eli Lilly and Company

INDUSTRY

NCT05824858 - A Study of the Effect of Food on LY3537982 in Healthy Participants | Biotech Hunter | Biotech Hunter